Tempus, a health technology company focused on personalized oncology care, will collect and analyze clinical and molecular data to support Moores Cancer Center’s research on immune checkpoint inhibitors across cancer types.
The company will also help the center incorporate genomic data into its clinical and research practices.
“Collecting and analyzing patients’ molecular, treatment and outcome data will be transformative for patients, researchers and the healthcare ecosystem,” said Eric Lefkofsky, co-founder and CEO of Tempus.
More articles on health IT:
Bloomberg: Kaspersky Lab tied to Russian government
3 Florida ACOs tap eClinicalWorks for population health management
Norwegian academic, healthcare institutions partner for blockchain research network
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
